Likewise, in the Hippo pathway, a negative regulator of proliferation in normal cells, loss-of-function mutations in NF2 and LATS1/2 genes and gene amplification of YAP gene as a gain-of-function mutation in cancers have been reported16. This evidence concerns the gene YAP1 and cancer.